CMS Open Payments · Program Year 2024
ZOLL Medical Corporation
ZOLL Medical Corporation reported $1,243,073.46 across General Payments, Research, and Ownership to 336 physicians and teaching hospitals across 362 transactions.
- $1.2M Above-median payer
- All-tracks total
- 362 Above-median volume
- Transactions
- 336 Above-median reach
- Recipients
- −$73.6K
- General Payments vs PY2023
ZOLL Medical Corporation reported $1,243,073.46 across all CMS Open Payments tracks (General + Research + Ownership) to 336 physicians and teaching hospitals in Program Year 2024 - ranking #569 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $677,598.39, averaging $3.7K per recipient.
How ZOLL Medical Corporation's $1.2M all-tracks total breaks down
ZOLL Medical Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
31/100
Total payments
F
21/100
Transaction volume
F
13/100
Physician reach
F
13/100
Payment type diversity
C
77/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer zoll-medical-corporation ZOLL Medical Corporation
$1.2M · #569/1,925 · 0.0% industry · PY2024
- TOT $1.2M
- RANK #569
- SHARE 0.0%
- TXN 362
- RCP 336
- CAT 6
- GEN $677.6K
- ΔGEN −$73.6K
- TOP1 30.3%
- PY 2024
Volume peers
Nearest volume peer: Hologic Sales and Service, LLC ($1.2M)
ZOLL Medical Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
ZOLL Medical Corporation's CMS-reported General Payments decreased by $73.6K (−9.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ZOLL MEDICAL CORPORATIONPY2023: ZOLL MEDICAL CORPORATIONPY2024: ZOLL Medical Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $751,154.92
- PY2024
- $677,598.39
What the Data Shows for ZOLL Medical Corporation
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For ZOLL Medical Corporation, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 6 general-payment categories charted below, "Consulting Fee" is the largest at $288.5K across 73 transactions, 42.6% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 6 types of general payments, ZOLL Medical Corporation's largest category was "Consulting Fee" at $288.5K - 42.6% of General Payments.
ZOLL Medical Corporation reports 6 general-payment categories - the top three are Consulting Fee (42.6%), Space Rental or Facility Fees (29.0%), and Compensation for Services Other Than Consulting (12.1%). The remaining 3 categories make up 16.3% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How ZOLL Medical Corporation divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $288.5K | 73 | 42.6% |
| Space Rental or Facility Fees | $196.2K | 32 | 29.0% |
| Compensation for Services Other Than Consulting | $82.0K | 24 | 12.1% |
| Honoraria | $74.5K | 19 | 11.0% |
| Travel and Lodging | $25.2K | 42 | 3.7% |
| Food and Beverage | $11.0K | 146 | 1.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $516,852.51 (76.3%) of $677,598.39 in this company's General Payments records across 173 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for ZOLL Medical Corporation
The five named recipients with the highest reported General Payments from this company
- 1
University Of Iowa Hosp & Clinics
$205,023.00 across 4 reported transactions
- 2
Osf Heart Of Mary Medical Center
$149,134.00 across 1 reported transactions
- 3
Fred S Willis
$78,000.00 across 13 reported transactions
- 4
Joseph Bart
$55,900.00 across 12 reported transactions
- 5
Elizabeth Hunt
$28,795.51 across 7 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
ZOLL Medical Corporation's spend rank (#569 of 1,925, top 30% by spend) and concentration rank (#831 of 1,838, top 45% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- OMNIlife science, Inc : $1.7M total payments, HHI 1654
- Takeda Pharmaceuticals U.S.A., Inc. : $72.8M total payments, HHI 1650
- Merck Healthcare KGaA : $85.4K total payments, HHI 1648
- Aesculap Implant Systems, LLC : $670.4K total payments, HHI 1647
- Marius Pharmaceuticals, Inc : $37.0K total payments, HHI 1645
- Menicon : $4.1K total payments, HHI 1644
- ZOLL Medical Corporation (this company) : $677.6K total payments, HHI 1640
- Servier Affaires Medicales : $70.3K total payments, HHI 1627
- Grifols, S.A. : $42.7K total payments, HHI 1621
- Evolution Spine, LLC : $263.2K total payments, HHI 1610
- Tigon Medical LLC : $32.6K total payments, HHI 1606
- Highridge Medical LLC : $5.8M total payments, HHI 1604
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as ZOLL Medical Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about ZOLL Medical Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with ZOLL Medical Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
DiaSorin Molecular LLC
Bioventus LLC
TearOptix, Inc.
Aerin Medical Inc.
Hyhte Holdings Inc.
Put this to use
ZOLL Medical Corporation ranks #569 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where ZOLL Medical Corporation sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just ZOLL Medical Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.